Skip to page content

Objective Analysis. Effective Solutions.

Site-wide navigation

About RAND
RAND Campaign
Press Room
Careers

Research
Research Areas
Trending Topics
All Topics Browse Reports
Research Divisions
Research Departments
Latest Insights
Reports
Is the Market for AI Foundation Models a Natural Monopoly?

Enabling Human Security from Space
Commentary and Articles
Ukraine's Kursk Incursion: Another Nail in the Coffin of Putin's Regime?

What Might Harris Do on North Korea if Elected President?
Multimedia
Climate Change and Critical Infrastructure: Assessing the Risks and Identifying Mitigation Strategies

The Policy Currents Podcast
Policy Experts
All Experts

Spotlight
- Naoko Aoki @naokoaoki
  
  Commentary:
  
  What Might Harris Do on North Korea if Elected President?
- William Courtney @courtneywmh
  
  Commentary:
  
  Nuclear Testing: A Second Coming?
By Research Area
Capabilities
Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms.
Capabilities Overview

RAND Solutions

Who We Work For

Public Sector

Philanthropic Sector

Private Sector

Work with Us

Explore Business Contacts

About RAND Research

Disciplinary Expertise

Quality Standards

Methodological Innovation
Featured Solutions
Getting to Know Military Caregivers and Their Needs

Managing Escalation in Crisis and War

Assessing and Articulating the Wider Benefits of Research

Improving Access to Early Childhood Education
Graduate School
The Pardee RAND Graduate School (PardeeRAND.edu) is home to the only Ph.D. and M.Phil. programs offered at an independent public policy research organization—the RAND Corporation.
Featured Video: Campus Tour

Student Life at Pardee RAND
Student Spotlight
- Sangita M. Baxi
  
  Assistant Policy Researcher; Ph.D. Candidate, Pardee RAND Graduate School
- Karishma V. Patel
  
  Ph.D. Candidate, Pardee RAND Graduate School, and Assistant Policy Researcher, RAND
About

中文(简体)
العربية
Cart

Site-wide Search

RAND
Topics
>Methamphetamine

Methamphetamine

Methamphetamine

Related Topics

Controlled Substances and Illegal Drugs
Obesity

Explore RAND’s Work on this Topic

Skip to results

Search by keyword

Content Type
- Journal Article (20)
- Report (4)
- News Release (3)
- Research Brief (2)
- Commentary (1)
- Multimedia (1)
- Periodical (1)
Region
Most relevant regions
- Americas (4)
- North America (4)
- United States (4)
- California (2)
- Pacific States (2)
- Southwestern States (2)
- Europe (1)
- Iran (1)
- Middle East (1)
- Netherlands (1)
Date
- Last 30 days
- Last 90 days
- Last year
- Last two years
to

32 Results

number of items to display at a time

Error

Journal Article

Feb 18, 2021

Mental Health, Physical Health, and Cultural Characteristics Among American Indians/Alaska Natives Seeking Substance Use Treatment in an Urban Setting: A Descriptive Study

We analyze substance use, AI/AN cultural identity and involvement, physical health and cognitive functioning, and mental health symptoms among 63 AI/AN adults seeking substance use treatment within an urban area in California.
News Release

Aug 20, 2019

Americans' Spending on Illicit Drugs Nears $150 Billion Annually; Appears to Rival What Is Spent on Alcohol

Spending on cannabis, cocaine, heroin and methamphetamine by Americans reached nearly $150 billion in 2016, with a large proportion of spending coming from the small share of people who use drugs on a daily or near-daily basis.
Report

Aug 20, 2019

What America's Users Spend on Illegal Drugs, 2006–2016

This report updates and extends estimates of the number of users, retail expenditures, and amount consumed from 2006 to 2016 for cocaine (including crack), heroin, marijuana, and methamphetamine in the United States.
Journal Article

Nov 21, 2017

Exploring the Perils of Cross-national Comparisons of Drug Prevalence: The Effect of Survey Modality

The methods of contacting respondents and the technology for questioning respondents in household surveys complicate cross-country comparisons of drug prevalence.
Journal Article

Feb 26, 2015

The Whole Is Just the Sum of Its Parts: Limited Polydrug Use Among the "Big Three" Expensive Drugs in the United States

Data from surveys of arrestees and the household population in the U.S. suggest there is only modest overlap among demand for the big three expensive illegal drugs (cocaine/crack, heroin, and methamphetamine).
Journal Article

Feb 2, 2015

How Much of the Cocaine Market Are We Missing? Insights from Respondent-Driven Sampling in a Mid-Sized American City

This paper uses respondent-driven sampling (RDS) of drug users in a mid-sized American city to estimate the shares of cocaine (powder and crack) users and expenditures that are attributable to different combinations of these groups.
Journal Article

Jan 28, 2015

How Group Factors Affect Adolescent Change Talk and Substance Use Outcomes: Implications for Motivational Interviewing Training

Clients who verbalize statements arguing for change (change talk [CT]) in psychotherapy are more likely to decrease alcohol and other drug use (AOD) compared with clients who voice statements in opposition of change (sustain talk [ST]).
Journal Article

Jul 9, 2014

Perceptions of Behavioral Health Care Among Veterans with Substance Use Disorders: Results from a National Evaluation of Mental Health Services in the Veterans Health Administration

Understanding patients' perceptions of care is essential for health care systems.
Commentary

Mar 10, 2014

Hard Drugs Demand Solid Understanding

Due to budget concerns the federal government just shut down a critical data source that provides insights into abuse, dependence on, and spending on heroin and other hard drugs like crack and methamphetamine.
News Release

Mar 10, 2014

U.S. Cocaine Consumption Declines by Half, While Marijuana Use Jumps

From 2006 to 2010, the amount of marijuana consumed by Americans increased by more than 30 percent, while cocaine consumption fell by about half. Meanwhile, heroin use was fairly stable throughout the decade.
Research Brief

Mar 10, 2014

How Big Is the U.S. Market for Illegal Drugs?

Using data from 2000 to 2010, RAND researchers estimated the number of users, expenditures, and consumption for four illicit drugs: cocaine (including crack), heroin, marijuana, and methamphetamine (meth).
Report

Mar 7, 2014

What America's Users Spend on Illegal Drugs: 2000–2010

RAND researchers generated national estimates of the total number of users, total expenditures, and total consumption for four illicit drugs from 2000 to 2010: cocaine (including crack), heroin, marijuana, and methamphetamine.

Previous
1
2
3
Next

Oops! An unexpected error has occurred.

Please try again. If you see this message repeatedly, there may be a problem with site functionality at this time. Thanks for your patience while we work to resolve the problem.

Subscribe to the Policy Currents newsletter

Email

See all newsletters

About

RAND is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest.

RAND History
Diversity, Equity, and Inclusion
Leadership
Research Integrity
Career Opportunities

Connect

Contact Us
Locations

I am interested in

Jobs at RAND
Media Resources
Congressional Resources
Doing Business with RAND
Supporting RAND
Educational Opportunities
Alumni Association

Follow

RAND on LinkedIn
RAND on Twitter
RAND on Facebook
RAND on YouTube
RAND on Instagram

Stay Informed

Subscribe to the Policy Currents newsletter for RAND insights on the issues that matter most.

Stay Informed

Policy Currents newsletter

Get updates from RAND delivered straight to your inbox.

Email

View all email newsletters

Resources

Multimedia
Latest Reports
Browse by Author
RAND Classics
Databases and Tools

Site Information

Site Map
PRIVACY POLICY
Support Policy
Feedback
Help

1776 Main Street
Santa Monica, California 90401-3208

RAND® is a registered trademark. © 2024 RAND Corporation. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.